US EditionRobocath launches FIH clinical study of second-generation robotic system in coronary artery disease
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Robocath Launches First-In-Human Clinical Study to Evaluate Robotic System for Coronary Artery Disease Procedures
Photo: Robocath Photo: Robocath tim.hodson Tue, 01/27/2026 - 10:45 Jan. 27, 2026 — Robocath has launched the world’s first FIH (First-In-Human) clinical study evaluating its new robotic system in coronary artery disease. This second-generation robot, developed thanks to the clinical and technological experience Robocath gained with its first robotic platform – which is already deployed in numerous centers worldwide – integrates unprecedented and…
Robocath launches FIH clinical study of second-generation robotic system in coronary artery disease
Robocath’s robotic platform Robocath has announced the launch of a first-in-human (FIH) clinical study evaluating its new robotic system in coronary artery disease. The study will recruit 20 patients with coronary artery disease, primarily complex cases representative of the routine activity of a catheterisation laboratory. It will be conducted at the Centre Cardiologique du Nord (CCN) in Saint-Denis, France, under the leadership of Mohammed Nej…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
